This review summarizes current findings on how ketone body metabolism, ketogenic diets, SGLT2 inhibitors and exogenous ketone body supplements affect kidney diseases. It describes ketone bodies as energy fuels that influence metabolism, inflammation and cellular crosstalk across organs. The abstract states the aim of clarifying the effects of ketone bodies on kidney disease to guide clinical treatment, and does not report specific results.
A goBHB specialist picks these up and answers inside one business day.